Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
CN Bio
CN Bio
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Rentschler Biopharma appoints Patrick Cushing as VP Operations for US subsidiary
The novel position will require Dr Cushing to manager operations at the Miford, MA facility in the US
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Johnson & Johnson submits regulatory application for Tremfya to the European Medicines Agency
The submission included data from the Phase 3 QUASAR programme in ulcerative colitis and the Phase 3 GALAXI programme in Crohn’s disease, which each achieved their primary...
Amolyt receives FDA fast track designation for hypoparathyroidism drug
The therapeutic has been awarded the fast track designation owing to the Phase III Calypso trial, which showed promising efficacy and safety features
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Marketing
CN Bio appoints Joseph Parisi as US Director of Sales
CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single- and multi-organ microphysiological systems (MPS), announces the appointment of Joseph Parisi as US Director of Sales
Research & Development
CN Bio wins "Most Impactful Industry Collaboration of the Year" at the OBN Awards
Six-year collaboration recognised at prestigious awards ceremony for its continued success in advancing OOC research to support widespread adoption across the pharmaceutical industry
Research & Development
CN Bio opens new laboratory facilities to extend OOC contract research services capabilities
State-of-the-art laboratories significantly expand project capacity to meet increasing market demand for organ-on-a-chip research services
Research & Development
CN Bio introduces PhysioMimix NASH ‘in-a-box’ reagent kit
Despite research efforts to combat the growing prevalence of NASH, to-date, there are no approved therapeutics
Research & Development
CN Bio and iiCON announce COVID-19 research collaboration
The £174m programme aims to bring together industry, academia, and clinicians to accelerate the discovery, development and deployment of treatments and products
Manufacturing
CN Bio launches oncology service for drug discovery
The service provides a means to explore the relationships between pharmacokinetics, pharmacodynamics (PK/PD) and efficacy in vitro
Research & Development
CN Bio licenses gut modelling tool from MIT
The GuMi device was licensed by Professor Linda Griffith at MIT's Department of Biological Engineering and joint patent-holder, Professor Rebecca Carrier at Northeastern University
Subscribe now